Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

Item
http://www.wikidata.org/entity/Q38378054
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen.Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelIn Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentPSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesBispecific protein targets prostate cancer64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen.Low level endogenous prostate-specific membrane antigen (PSMA) expression in non-prostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging.Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine
P2860

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

Item
http://www.wikidata.org/entity/Q38378054
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
type
label
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
prefLabel
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
P2093
P304
P31
P356
10.2174/1874471008666150313114005
P433
P478
P577
P698